Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief Review

Definitive pharmacological therapies for COVID-19 have yet to be identified. Several hundred trials are ongoing globally in the hope of a solution. However, nearly all treatments rely on systemic delivery but COVID-19 damages the lungs preferentially. The use of a targeted delivery approach is revie...

Descripción completa

Detalles Bibliográficos
Autores principales: Kipshidze, Nicholas, Iversen, Patrick, Porter, Thomas R., Kipshidze, Nodar, Siddiqui, Fakiha, Dangas, George, Fareed, Jawed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498969/
https://www.ncbi.nlm.nih.gov/pubmed/32936689
http://dx.doi.org/10.1177/1076029620954911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498969/
https://www.ncbi.nlm.nih.gov/pubmed/32936689
http://dx.doi.org/10.1177/1076029620954911

Ejemplares similares